Figure 2.

Patient selection and attrition. Identification period: October 1, 2015 through June 30, 2016. Index date: date of first pharmacy claim for SAC/VAL or ACEI/ARB. ACEI/ARB indicates angiotensin‐converting enzyme inhibitor or angiotensin‐receptor blocker; CRT/ICD, cardiac resynchronization therapy/implantable cardioverter‐defibrillator; HFrEF, heart failure with reduced ejection fraction; MI, myocardial infarction; PDC, proportion of days covered; SAC/VAL, sacubitril/valsartan. *Criteria for claims evidence of HF and stable status are provided in Figure 1. ^†Variables used in propensity score matching are provided in Table 1.